Testing effectiveness (Phase 2)Study completedNCT00390143
What this trial is testing
Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612
Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 46